Steady‐state pharmacokinetics of (R)‐ and (S)‐methadone in methadone maintenance patients
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Aims To investigate the steady‐state pharmacokinetics of (R)‐ and (S)‐methadone in a methadone maintenance population. Methods Eighteen patients recruited from a public methadone maintenance program underwent an interdosing interval pharmacokinetic study. Plasma and urine samples were collected and analysed for methadone and its major metabolite (EDDP) using stereoselective h.p.l.c. Methadone plasma protein binding was examined using ultrafiltration, and plasma α 1‐acid glycoprotein concentrations were quantified by radial immunoassay. Results (R)‐methadone had a significantly (P < 0.05) greater unbound fraction (mean 173%) and total renal clearance (182%) compared with (S)‐methadone, while maximum measured plasma concentrations (83%) and apparent partial clearance of methadone to EDDP (76%) were significantly (P < 0.001) lower. When protein binding was considered (R)‐methadone plasma clearance of the unbound fraction (59%) and apparent partial intrinsic clearance to EDDP (44%) were significantly (P < 0.01) lower than for (S)‐methadone, while (167%) was significantly (P < 0.001) greater. There were no significant (P > 0.2) differences between the methadone enantiomers for , steady‐state plasma clearance, trough plasma concentrations and unbound renal clearance. Patients excreted significantly (P < 0.0001) more (R)‐methadone and (S)‐EDDP than the corresponding enantiomers. Considerable interindividual variability was observed for the pharmacokinetic parameters, with coefficients of variation of up to 70%. Conclusions Steady‐state pharmacokinetics of unbound methadone are stereoselective, and there is large interindividual variability consistent with CYP3A4 mediated metabolism to the major metabolite EDDP; the variability did not obscure a significant dose‐plasma concentration relationship. Stereoselective differences in the pharmacokinetics of methadone may have important implications for pharmacokinetic‐pharmacodynamic modelling but is unlikely to be important for therapeutic drug monitoring of methadone, in the setting of opioid dependence.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Shimada, T., Yamazaki, H., Mimura, M., Inui, Y., & Guengerich, F. P. (1994) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22379-5 · Cited by 2,785
Dole, V. P. (1965) · JAMA · doi:10.1001/jama.1965.03090080008002 · Cited by 1,240
Altered methadone pharmacokinetics in methadone-maintained pregnant women.
Pond, S. M., Kreek, M. J., Tong, T. G., Raghunath, J., & Benowitz, N. L. (1985) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)21130-2 · Cited by 189
Kreek, M. J., Bencsath, F. A., & Field, F. H. (1980) · Biological Mass Spectrometry · doi:10.1002/bms.1200070906 · Cited by 33
Cited by
Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017
Hiemke, C., Bergemann, N., Clement, H., Conca, A., Deckert, J., Domschke, K., Eckermann, G., Egberts, K., Gerlach, M., Greiner, C., et al. (2018) · Pharmacopsychiatry · doi:10.1055/s-0043-116492 · Cited by 1,446
Eap, C. B., Buclin, T., & Baumann, P. (2002) · Clinical Pharmacokinetics · doi:10.2165/00003088-200241140-00003 · Cited by 599
Hyperalgesic responses in methadone maintenance patients
Doverty, M., White, J. M., Somogyi, A. A., Bochner, F., Ali, R., & Ling, W. (2001) · Pain · doi:10.1016/s0304-3959(00)00391-2 · Cited by 297
“R-(2)- and S-(1)-methadone were quanti®ed in plasma using high-performance liquid chromatography (HPLC) as described by Foster et al. (2000).”
Self-citationRole of CYP2B6 in Stereoselective Human Methadone Metabolism
Totah, R. A., Sheffels, P., Roberts, T., Whittington, D., Thummel, K., & Kharasch, E. D. (2008) · Anesthesiology · doi:10.1097/aln.0b013e3181642938 · Cited by 192
“There is large interindividual variability (20- to 100-fold) in methadone clearance.(4,6) Moreover, methadone drug interactions occur with CYP inducers such as rifampin(7,8) and phenytoin,(9) and CYP inhibitors such as antidepressants, antifungal agents, and antiretroviral drugs.”
BackgroundResultInfluentialLintzeris, N., Monds, L. A., Rivas, C., Leung, S., Dunlop, A., Newcombe, D., Walters, C., Galea, S., White, N., Montebello, M., et al. (2018) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000396 · Cited by 34
Metadata
- Authors
- Foster, D. J. R., Somogyi, A. A., Dyer, K. R., White, J. M., & Bochner, F.
- Venue
- British Journal of Clinical Pharmacology
- Publisher
- Wiley
- Published
- 2000-11
- Volume
- 50
- Issue
- 5
- Pages
- 427-440
- ISSN
- 0306-5251 (ISSN-L)
- 1365-2125
- OpenAlex
- W1497037168
- Cited by
- 129
- References
- 4
- FWCI
- 5.37
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Steady‐state pharmacokinetics of (R)‐ and (S)‐methadone in methadone maintenance patients. https://app.cochat.ai/papers/10.1046/j.1365-2125.2000.00272.x
- The paper
- Foster, D. J. R., Somogyi, A. A., Dyer, K. R., White, J. M., & Bochner, F. (2000). Steady‐state pharmacokinetics of (R)‐ and (S)‐methadone in methadone maintenance patients. British Journal of Clinical Pharmacology. https://doi.org/10.1046/j.1365-2125.2000.00272.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.